This PDF is the current document as it appeared on Public Inspection on 12/19/2014 at 08:45 am.
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on January 20, 2015. The topic for this meeting will be a report and discussion of the findings of a recent consensus conference on glucose monitoring. The meeting is open to the public.
The meeting will be held on January 20, 2015 from 1:30 p.m. to 4:00 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date.Start Printed Page 76343
The meeting will be held in Building 45 Conference Room D, on the NIH Campus in Bethesda, MD.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For further information concerning this meeting, see the DMICC Web site, www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-6623; FAX: 301-480-6741; email: email@example.com.End Further Info End Preamble Start Supplemental Information
The DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The January 20, 2015 DMICC meeting will focus on outcomes from a consensus conference held jointly by the American Association of Clinical Endocrinologists and the American College of Endocrinology, which took place September 28-29, 2014.
Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification about future DMICC meetings should register for the listserv available on the DMICC Web site, www.diabetescommittee.gov.Start Signature
Dated: December 15, 2014.
B. Tibor Roberts,
Executive Secretary, Office of Scientific Program and Policy Analysis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
[FR Doc. 2014-29883 Filed 12-19-14; 8:45 am]
BILLING CODE 4140-01-P